"FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS"
Application 526/DELNP/2005 published 2007-01-19, filed 2005-02-10
A liquid aqueous pharaceutical formulation is described which has a high protein concentration, a pH of between about 4 and about 8, and enhanced stability.
Applicant
1)ABOTT BIOTECHNOLOGY LTD
:CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 BERMUDA Bermuda
Inventor
1)KRAUSE HANS-JUERGEN 2)BAUST LISA 3)DICKES MICHAEL
International Info
Classification: A61K 39/395
Publication Number: WO 2004/016286
Application Date: 2003-08-15
Priority Information
22/222,140 U.S.A. 2002-08-16